TRUCS THERAPEUTICS LIMITED

11749031
Active Bicester

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
T

TRUCS THERAPEUTICS LIMITED

11749031

Research and experimental development on biotechnology

Founded 4 Jan 2019 Active Bicester, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Due 31 Mar 2026 3 months overdue
Confirmation Submitted 19 Sept 2025 Next due 19 Sept 2026 3 months remaining
Net assets £2M £34K 2024 year on year
Total assets £2M £62K 2024 year on year
Total Liabilities £21K £28K 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

2 Minton Place Victoria Road Bicester Oxon OX26 6QB United Kingdom

Full company profile for TRUCS THERAPEUTICS LIMITED (11749031), an active company based in Bicester, United Kingdom. Incorporated 4 Jan 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2024
Type small
Next accounts 30 Jun 2025
Due by 31 Mar 2026 3 months overdue

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£259.73k

Decreased by £95.75k (-27%)

Net Assets

£1.75M

Decreased by £33.71k (-2%)

Total Liabilities

£20.71k

Decreased by £28.14k (-58%)

Turnover

N/A

Employees

N/A

Debt Ratio

1%

Decreased by 2 (-67%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
30 Jun Year End
2023
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Gavin WoodDirectorBritishUnited Kingdom5610 Jul 2023Active
Hill, Christopher JamesDirectorBritishEngland4614 Nov 2025Active
Margaret HenryDirectorBritishUnited Kingdom5710 Jul 2023Active

Shareholders

Shareholders (1)

Tcr2 Therapeutics Inc.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 1 Jun 2023
Nature of Control
  • Significant Influence Or Control As Firm

Group Structure

Group Structure

TRUCS THERAPEUTICS LIMITED Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Nov 2025OfficersTermination of William Charles Bertrand as director on 14 Nov 2025
14 Nov 2025OfficersAppointment of Mr Christopher James Hill as director on 14 Nov 2025
14 Nov 2025OfficersTermination of Adrian George Rawcliffe as director on 14 Nov 2025
6 Oct 2025OfficersAppointment of Mr Adrian George Rawcliffe as director on 30 Sept 2025
6 Oct 2025OfficersAppointment of Mr William Charles Bertrand as director on 30 Sept 2025
14 Nov 2025 Officers

Termination of William Charles Bertrand as director on 14 Nov 2025

14 Nov 2025 Officers

Appointment of Mr Christopher James Hill as director on 14 Nov 2025

14 Nov 2025 Officers

Termination of Adrian George Rawcliffe as director on 14 Nov 2025

6 Oct 2025 Officers

Appointment of Mr Adrian George Rawcliffe as director on 30 Sept 2025

6 Oct 2025 Officers

Appointment of Mr William Charles Bertrand as director on 30 Sept 2025

Recent Activity

Latest Activity

Termination of William Charles Bertrand as director on 14 Nov 2025

7 months ago on 14 Nov 2025

Appointment of Mr Christopher James Hill as director on 14 Nov 2025

7 months ago on 14 Nov 2025

Termination of Adrian George Rawcliffe as director on 14 Nov 2025

7 months ago on 14 Nov 2025

Appointment of Mr Adrian George Rawcliffe as director on 30 Sept 2025

8 months ago on 6 Oct 2025

Appointment of Mr William Charles Bertrand as director on 30 Sept 2025

8 months ago on 6 Oct 2025